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SUMMARY
A study was carried out to determine the effect of 
established and gestational diabetes on pregnancy 
outcome over a period of two years at Harare 
Maternity Hospital, Harare, Zimbabwe. During the 
period, 51 patients with established diabetes mellitus 
and 70 patients with gestational diabetes were 
treated. The perinatal mortality was higher among 
this group (124 per 1 000) compared with the rest of 
the total hospital population (44 per 1 000) who 
delivered during the same period.
INTRODUCTION
Established diabetes is well recognised as a cause of 
increased perinatal mortality (Connell et al 1985) 
whilst the clinical significance of abnormal glucose 
to le ran ce  id en tified  in p regnancy  rem ains 
controversial (Beard and Hoet 1982, Jarret, R J, 1981, 
Al-Sawafefa/ 1988).
In Harare Maternity Hospital, the patients with 
established diabetes mellitus are treated with insulin 
and those with glucose intolerance first diagnosed in 
pregnancy (gestational diabetes) are treated with diet 
alone or with diet and insulin.
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The purpose of this study was to determine the 
foetal outcome on women with established diabetes 
and gestational diabetes as measured by perinatal 
mortality and foetal birth-weight.
MATERIALS AND METHODS
A retrospective analysis of the records of all patients 
who had established diabetes and those with 
gestational diabetes and delivered at Harare 
Maternity Hospital between January 1, 1990 to 
December 31,1991 was done.
Diabetes was classified as “established” if the 
disease was known to be present and was being 
treated before pregnancy. These were mainly patients 
referred from city clinics, Harare Hospital Medical 
OPD, District and Provincial hospitals and general 
practitioners.
A diagnosis of gestational diabetes was made in a 
pregnant women whose carbohydrate intolerance 
was first recognised during that current pregnancy 
using WHO (1980) criteria.
At booking of a current pregnancy, selective 
screening with a glucose load test was done in any 
woman with any of the following risk factors: namely 
previous history of unexplained still-births, previous 
delivery of macrosomic baby (birth-weight >4kg), 
first degree relative with insulin dependent diabetes 
mellitus, polyhydromnious in current pregnancy, 
glycosuria on more than two occasions and those with 
bad obstetric history.
To perform the glucose load test, 50gm of oral 
glucose is given to the pregnant woman without 
regard to time of day or last meal. If the venous 
plasma glucose level measures one hour later is > 7.8 
m m ol/1 a complete glucose tolerance test is 
performed (Beard et al 1980, O’Sullivan etal 1973b).
At Harare Maternity Hospital, an oral glucose 
tolerance Jest (OGTT) is performed with a 75gm 
glucose load in a patient who has starved from the 
previous night and glucose intolerance is shown by 
fasting blood glucose levels at > 6.0 mmol/1 and 
2-hour levels of > 7 mmol/1.
Once a diagnosis of gestational diabetes is 
established from OGTT, treatment starts with a 
diabetic diet and if subsequent glucose profiles do not 
show acceptable glucose haemostasis of between 
4-6m m ol/l, insulin treatment is commenced (Fraser 
R B, 1991, Burdnell, M and Doddridge, M C 1989).
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RESULTS
A total of 121 patients were treated from January 
1990 to December 1991. This represents about 0,04 
pc of all deliveries during that period. Of the 121 
cases, 51 (42 pc) were established diabetes and 70 (58 
pc) were gestational diabetes. Among the gestational 
diabetics only 19 (27 pc) were treated with diet 
compared with 51 (73 pc) who were treated with diet 
and insulin.
Table I shows that perinatal mortality rate is higher 
for the diabetic patients (124 per 1000), compared to 
the total hospital population (44 per 1000). 
Established diabetics had a higher perinatal mortality 
(196 per 1000) compared to those with gestational 
diabetics (71 per 1000).
Table /: Perinatal Mortality
Group All
deliveries
All
babies born
Still-births 
(per 1 0 0 0  births)
Total hospital 
population 34 ,3 6 2 3 5 ,4 5 4 1 5 5 5  (44)
Established
diabetics 51 51 1 0 (1 9 6 )
Gestational
diabetics 7 0 70 5 (7 1 )
Table II shows details of perinatal deaths. The excess 
loss of macerated still-births, with no explanation for 
the deaths, tended to occur in late pregnancy and in 
macrosomic babies whose mothers were on insulin.
DISCUSSION
It is important to point out the disadvantages of this 
study: firstly that data collection was retrospective, 
resulting in possible inaccuracy on total number of 
patients with diabetes in pregnancy. This may explain 
why there is such a small number (less than 1 pc) of 
diabetics in the pregnant population at Harare 
Maternity Hospital. However, a community-based 
study to estimate the incidence of gestational diabetes 
would be more accurate.
In most regions of the world, the incidence of 
gestational diabetes varies from 1,6 pc to 2,5 pc 
(Beard R W, 1982, O’Sullivan J V, 1973). A strict 
c rite ria  of diagnosis should be followed as 
recommended by W.H.O. (1980).
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Table II: Details o f Perinatal Deaths
A ge (yrs) Parity Type of 
d iabetes
O utcom e
1. 38 8 G.D. R uptured uterus, fresh SB at 
term , 4357  gm
2. 32 5 IDDM Breech, IUD at term 6100 gm
3. 39 3 IDDM E m ergency LSCS for arm 
pro lapse, 4100  gm, died 1/7
4. 17 0 IDDM IUD a t 30  w ks, 2630 gm
5. 39 5 IDDM M acerated S B  at term  
6400 gm
6. 34 7 IDDM M acerated S B  a t 34 w ks 
2500 gm
7. 19 1 IDDM S B  a t 39  w ks 3800 gm
8. 38 9 G D  +  P IH SB a t 35  w ks 2100 gm
9. 24 1 GD Preterm  labour at 30 w ks, 
1900 gm , N eonata l death  
a t 2/7
10. 31 7 IDDM  + PIH M acerated S B  a t 28  w ks 
800 gm
11. 39 5 IDDM H ydrocepha lus + sp ina  b ifida 
diagnosed by USS at 35 w ks, 
decom pression of head done
12. 26 3 IDDM + PIH Ketoacedosis at 30 w ks 
m acerated SB 1110 gm
13. 32 5 IDDM Referred at 36 w ks on oral 
hypoglycaem ics, m acerated 
SB 6100 gm
14. 35 5 GD + PIH IUD at 37  w ks 4400 gm
1 5 . 40 4 GD + PIH M acerated SB at 34 w ks 
2500 gm.
CD = Gestational Diabetes
IDDM = Insulin Dependent Diabetes Mellitus
SB = Still-born
IUD = Intra Uterine Death
PIH -  Pregnancy Induced Hypertension
LSCS =  Lower Segment Caesarean Section
USS = Ultra Sound Scan
Although the numbers in the study are small, there 
is, however, a clearly defined poor outcome among 
the 121 diabetic pregnancies treated at Harare 
Hospital in 1990/91.
The majority had detailed ultra-sound scan in late 
second trimester and only one was found to have CNS 
malformation. Post mortem examinations were not 
perform ed on the still-born babies but gross 
macroscopic inspection did not show malformations.
Intra-uterine death occurred more commonly 
among women with established diabetes than those 
with gestational diabetes probably because of poor 
control in the earlier group. The outcome was even 
poorer when a women had established diabetes with 
pregnancy induced hypertension.
Late referral in established diabetes results in poor 
control and subsequent higher foetal loss as shown by 
Case 12 who was sent from a district hospital at 30 
weeks in ketoacidosis. Case 13 who was referred at 
36 weeks on chlopropramide illustrates why we do 
not use oral hypoglycaemic drugs in pregnancy 
because of poor control and risk of congenital 
malformation (Brudness M et al, 1989).
The long-term implications for this study are firstly 
to establish the normal glucose haemostasis among 
pregnant and non-pregnant Zimbabwean women of 
reproductive age. Secondly, we would like a 
prospective study on established and gestational 
diabetics to see if present management an be 
improved for a better outcome on this population.
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